Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oncoxin (also known as Ocoxin or Ocoxin Oral Solution) is an orally administered nutritional supplement composed of amino acids, vitamins, minerals, and a variety of natural antioxidants and plant extracts. It is designed to support cancer patients undergoing chemotherapy or radiotherapy by reducing treatment-related side effects such as oral mucositis and improving quality of life. Preclinical studies indicate that Oncoxin exerts antitumoral effects by slowing tumor cell proliferation and inducing apoptosis through mechanisms including cell cycle arrest at G2/M phase. The supplement also demonstrates antioxidant and anti-inflammatory properties. Clinical trials suggest it may help reduce the severity of adverse reactions to cancer therapies without significant toxicity[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oncoxin (279bf0).